Morgan Lewis (New York)

Harry Robins

Morgan Lewis (New York)
Partner

Harry Robins represents clients, including a number of prominent private equity firms and Fortune 500 companies from industries such as life sciences, publishing, electronics and chemicals, before the U.S. Federal Trade Commission and the U.S. Department of Justice, as well as international regulatory agencies, in connection with antitrust issues in mergers and acquisitions and joint venture transactions. Harry heads Morgan Lewis’ transactional antitrust practice. He also handles litigation and counseling matters, including class action litigation and government investigations.

Linked authors

Morgan Lewis (Washington)
Morgan Lewis (Washington)
Morgan Lewis (Washington)
Morgan Lewis (London)
Morgan Lewis (New York)

Articles

1782 Bulletin

David R. Brenneman, Maria Luisa Di Lauro, Harry T. Robins The US President Biden signs into law the 2023 spending bill which includes dramatically increasing funding for antitrust enforcers, and modernizing merger filing fees

132

In what appears to have been in part a trade for tabling new antitrust legislation, at least for now, the Biden administration dramatically increased funding for the Federal Trade Commission and the Antitrust Division of the Department of Justice. It remains unclear whether this additional (...)

Harry T. Robins, David R. Brenneman, Bernard W. Archbold The US FTC lowers the thresholds for acquisitions meaning that transactions more than $92 million require preclosing filing and approval

261

The Federal Trade Commission (FTC) announced on February 1 that it will lower the Hart­-Scott-­Rodino Act (HSR Act) jurisdictional and filing fee thresholds. Any transaction closing on or after March 4, 2021 will be subject to the revised thresholds. The new rules include a decrease in the “size (...)

Harry T. Robins, David R. Brenneman The US DoJ and FTC publish a public statement regarding their ongoing commitment to antitrust enforcement in mergers and acquisitions during the COVID-19 crisis

133

US antitrust laws already on the books facilitate rapid investment without government delay: important practical tools and rules for dealmakers and their counsel in the wake of the coronavirus (COVID-19) pandemic and the current economic challenges. Recently, leaders of both the US Antitrust (...)

Send a message